Product Safety Recalls

Product Recall Tracker

Recall D-0165-2025

Description: Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA

Recall D-0165-2025 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0165-2025
Event ID95900
DistributionNationwide in the US
Quantitya) 1,564 cards, b) 799 bottles
Recall ReasonCGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
Drug ClassificationClass II
Drug Code Info20250101
Recall Initiation Date20241202
Report Date20250101
Classification Date20241226
Address625 Kolter Dr Ste 4
Indiana, PA 15701-3571
United States
Recalling FirmRemedyRepack Inc.
Initial Notification Letter
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.